Scopus Biopharma Inc  (SCPS)
Other Ticker:  


Scopus Biopharma Inc

SCPS's Financial Statements and Analysis

Scopus Biopharma Inc increased III. Quarter net loss per share of $-0.09 compare to net loss per share of $-0.08 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.16 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.09 $  0 Mill
$-0.01     Unch.    

Scopus Biopharma Inc's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.

Scopus Biopharma Inc is Expected to report next financial results on April 14, 2023.

More on SCPS's Income Statement

Scopus Biopharma Inc's in III. Quarter recorded net loss of $-1.899 million, an increase from net loss of $-1.400 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-3.320 million realized in previous quarter.

More on SCPS's Growth

In III. Quarter company's net cash and cash equivalents decreased by $-1 million

Scopus Biopharma Inc does not pay out common stock dividend.

In trailing twelve-month period Scopus Biopharma Inc payed $ -0.56 cash per share, on a free-cash flow basis .